ARCA biopharma, Inc.

ARCA biopharma, Inc.

Sector: Pharmaceutical Preparations Region: CO, United States

: | Nasdaq: ABIO

Similar to: AstraZeneca Plc, Shire PLC, Pernix Therapeutics Holdings, Inc.

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.

News & Analysis

You may also be interested in: